Diabetes-specific formula with standard of care improves glycemic control, body composition, and cardiometabolic risk factors in overweight and obese adults with type 2 diabetes: results from a randomized controlled trialdoi:10.3389/fnut.2024.1400580Siew Ling Tey...
Clinical insights on the standard-of-care treatment of patients with advanced RAI-R-DTC, the NCCN guideline recommendations, and challenges encountered in treatment.This is a modal window. This video is either unavailable or not supported in this browserError Code: MEDIA_ERR_SRC_NOT_SUPPORTED...
There is currently a worldwide epidemic of type 2 diabetes (T2D) that is predicted to increase substantially in the next few years. With 80% of the global T2D population living in low to...doi:10.1007/s13300-019-0573-yViswanathan Mohan...
Between September 16, 2022, and September 16, 2023, we conducted a prospective, open-label, single-arm study to assess the use of ruxolitinib combined with standard of care for the treatment of severe hospitalized SFTS at the Qilu Hospital of Shandong University (Additional file 1: Fig. S1)...
Importance A stepwise approach that includes screening and lifestyle modification followed by the addition of metformin for individuals with high risk of diabetes is recommended to delay progression to diabetes; however, there is scant evidence regarding whether this approach is cost-effective. Objective...
EP: 15.Defining the Standard of Care for Early Breast Cancer Treatment EP: 16.Balancing Clinical and Economic Factors in Early Breast Cancer Treatment EP: 17.Alternative Treatments for eBC and mBC EP: 18.Navigating Therapy Approval for Early Breast Cancer: An Operational Perspective EP: 19.Br...
Article Published: 06 April 2023 Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trialXiao Tong Teong, Kai Liu, Andrew D. Vincent, Julien Bensalem, Bo Liu, Kathryn J. ...
A late-breaking abstract presented at the American Society of Hematology Annual Meeting and Exposition supports the addition of subcutaneous daratumumab to standard-of-care bortezomib, lenalidomide, and dexamethasone (VRd) in patients with newly diagnose
The performance of genome sequencing as a first-tier test for neurodevelopmental disorders Bart P. G. H. van der Sanden Gaby Schobers Lisenka E. L. M. Vissers European Journal of Human Genetics (2023) Integrated multi-omics for rapid rare disease diagnosis on a national scale Sebastian...
European Journal of Medical Research (2023) 28:22 https://doi.org/10.1186/s40001-023-00991-1 European Journal of Medical Research RESEARCH Open Access Comparison of telemonitoring combined with intensive patient support with standard care in patients with chronic cardiovascular disease ...